Welcome to our dedicated page for Raytech Holding SEC filings (Ticker: RAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking margin swings across multiple OEM contracts or spotting when Raytech ramps tooling for a new hair-dryer line can be buried deep in regulatory text. Raytech Holding Limited’s disclosures span hundreds of pages, and each Form 4 or 8-K may signal shifts in its personal-care appliance business. Stock Titan surfaces those signals the moment they reach EDGAR.
Need the Raytech Holding Limited annual report 10-K simplified? Our AI pinpoints how currency moves affect component costs and shows where segment revenue splits between hair styling and grooming tools. Curious about executive sentiment? The platform streams Raytech Holding Limited Form 4 insider transactions real-time, providing context around option grants and share sales. Every filing type is covered, from the Raytech Holding Limited quarterly earnings report 10-Q filing that details raw-material expense trends to the Raytech Holding Limited proxy statement executive compensation that clarifies incentive plans tied to OEM volumes.
Here’s how investors use these insights:
- Monitor Raytech executive stock transactions Form 4 before new product launches.
- Compare tooling cap-ex quarter-over-quarter with our Raytech Holding Limited earnings report filing analysis.
- Stay alert to supply-chain shocks via Raytech Holding Limited 8-K material events explained.
Whether you google “Raytech Holding Limited SEC filings explained simply” or ask an AI, you’ll land here. Stock Titan’s AI-powered summaries translate complex accounting into clear language, deliver insider trading Form 4 transactions straight to your dashboard, and answer natural questions like “understanding Raytech SEC documents with AI.” With real-time alerts, comprehensive coverage and expert context, you no longer spend hours combing PDFs—just the focused insights that drive decisions.
Evolent Health, Inc. (EVH) filed a Form 4 reporting an equity-based compensation grant to President Daniel J. McCarthy. On 07/01/2025 Mr. McCarthy received 44,767 Class A common shares in the form of restricted stock units (RSUs) under the Amended and Restated 2015 Omnibus Incentive Compensation Plan at an effective purchase price of $0.00. Following the award, his aggregate beneficial ownership increased to 433,771 shares.
The award vests on a staggered schedule: 34 % on 07/01/2026, and 33 % on each of 07/01/2027 and 07/01/2028. These RSUs represent the second portion of the annual grant cycle; issuance was contingent on shareholder approval of additional plan shares, which occurred at the 06/05/2025 annual meeting.
No derivative securities were reported, and the filing indicates direct ownership. The transaction neither involved open-market purchases nor sales; therefore, it does not immediately alter the public float but does expand future fully-diluted share count once the RSUs settle.
Raytech Holding Limited (Nasdaq: RAY) has filed a Rule 424(b)(4) prospectus for a best-efforts public offering of 25,985,000 ordinary shares at US$0.20 per share, potentially raising gross proceeds of US$5.20 million and net proceeds (before expenses) of US$4.83 million. Post-offering, total shares outstanding will rise to 43,598,083. CEO & Chairman Mr. Ching Tim Hoi will retain 12.8 million shares (29.4% voting power), ending Raytech’s previous “controlled company” status under Nasdaq rules.
Business model. Through wholly-owned Hong Kong subsidiary Pure Beauty, Raytech designs, sources and wholesales personal-care electrical appliances (hair dryers, straighteners, trimmers, etc.) for international brand owners. Hair-styling products contributed 48% of FY-2024 revenue; Koizumi Seiki Corp. alone accounted for 74% of FY-2024 sales, indicating material customer concentration. Manufacturing is almost entirely outsourced to two mainland-China factories—one (Zhongshan Raytech) is controlled by the CEO and supplied 88.5% of FY-2024 production.
Recent developments. • Auditor change (WWC, P.C. dismissed; Assentsure PAC appointed) effective April 9 2025.
• Board refresh: resignation of independent director Mr. Yiu Wing Hei; appointment of Mr. Li Shihua (May 19 2025) as independent director & audit-committee chair.
Regulatory landscape. Operations are in Hong Kong; Raytech has no PRC subsidiaries or VIE structure and believes—per PRC and Hong Kong counsel—that no CAC/CSRC approvals are currently required. Nonetheless, management highlights potential PRC “long-arm” intervention, national-security considerations, CSRC filing uncertainties and HFCA/AHFCAA delisting risk should PCAOB access change. Auditor WWC is U.S.-based and currently inspected by PCAOB.
Use of proceeds. According to the prospectus (p. 59), roughly 20% will fund international marketing (U.S., EU, Asia), 30% will expand headcount (sales, R&D, admin), and the balance will support working capital and product-line expansion (men’s grooming, oral care).
Key investment considerations
- Small capital raise (≈US$5 m) but highly dilutive—share count increases 148% versus pre-offering.
- High customer (Koizumi) and supplier (Zhongshan Raytech) concentration exposes earnings to single-counterparty risk.
- Regulatory uncertainty in Hong Kong/Mainland-China relations and potential HFCA compliance issues may weigh on valuation.
- Positive tailwinds from global personal-care appliance growth (forecast 5.5–7% CAGR) and Raytech’s 11-year operating history with established Japanese customer base.
FAQ
What is the current stock price of Raytech Holding (RAY)?
What is the market cap of Raytech Holding (RAY)?
What is Raytech Holding Limited’s core business?
Which product lines are central to Raytech's operations?
How does Raytech cater to international brand owners?
What makes Raytech's manufacturing process unique?
How does Raytech differentiate itself from competitors?
What are some of the key product categories offered by Raytech?
Who are the primary customers of Raytech Holding Limited?
What strategic advantages support Raytech’s market position?
